Status:
UNKNOWN
COVID-19 IgG Antibodies in the Serum of Recovered Patients
Lead Sponsor:
Assiut University
Conditions:
Covid19
Eligibility:
All Genders
20+ years
Brief Summary
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in China, in December 2019 and is now spreadin...
Eligibility Criteria
Inclusion
- Adults aged ≥ 20 years.
- Prior COVID-19 infection confirmed by PCR detection of SARS-CoV-2 RNA or antigen in nasopharyngeal swab.
- Recovery from infection either confirmed by two consecutive negative PCR (collected ≥24 hours apart) or passing of 14 days since onset of COVID-19 symptoms and at least 3 days since resolution of fever without the use of antipyretics and improvement of respiratory symptoms
Exclusion
- Presence of any chronic illness interfere with immunity (autoimmune diseases).
- Pregnancy.
- Recovery from three months or more.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04470414
Start Date
August 1 2020
End Date
September 1 2021
Last Update
July 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine- Assiut university
Asyut, Egypt